{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:59:55Z","timestamp":1783702795867,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Clinical Research Special Fund for Central High-level Hospital","award":["2023-GSP-GG-33"],"award-info":[{"award-number":["2023-GSP-GG-33"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the efficacy and safety of adding Superior Vena Cava Isolation (SVCI) to Pulmonary Vein Isolation (PVI) in patients with drug-refractory paroxysmal atrial fibrillation (PAF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review and meta-analysis of randomised controlled trials (RCTs) using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, supplemented with Trial Sequential Analysis (TSA) to assess evidence sufficiency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data sources<\/jats:title>\n                  <jats:p>We searched PubMed, EMBASE, the Cochrane Library (CENTRAL) and Web of Science for relevant studies published up to 13 July 2025.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Eligibility criteria<\/jats:title>\n                  <jats:p>We included prospective RCTs comparing SVCI+PVI versus PVI alone in adults with drug-refractory PAF, with at least 3 months of follow-up and reporting on atrial fibrillation (AF) recurrence and procedural complications. Case reports, reviews, observational studies, editorials, expert opinions and non-RCT studies were excluded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data extraction and synthesis<\/jats:title>\n                  <jats:p>Two independent reviewers used standardised methods to search, screen and code included studies. Risk of bias was assessed using the Cochrane Collaboration and Evidence Project tools. A meta-analysis was conducted using random effects models, and TSA was conducted to evaluate the conclusiveness of evidence. Findings were summarised in GRADE evidence profiles and synthesised qualitatively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three RCTs involving 332 patients were included. The addition of SVCI to PVI significantly reduced AF recurrence compared with PVI alone (Risk Ratio 0.54, 95%\u2009CI 0.32 to 0.91, p=0.02; I\u00b2 = 0%, P_heterogeneity=0.79) at a mean 12-month follow-up. TSA confirmed that the current evidence is sufficient. There were no significant differences in procedural complications between groups (Risk Difference 0.00, 95%\u2009CI \u20130.04 to 0.03, p=0.99; I\u00b2 = 0%, P_heterogeneity=0.96).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adding SVCI to PVI for PAF ablation significantly reduces AF recurrence without increasing procedural risks. TSA confirms the robustness of the findings, supporting the potential integration of SVCI into routine clinical practice for PAF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095135","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:35:34Z","timestamp":1757352934000},"page":"e095135","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Superior vena cava isolation added to pulmonary vein isolation enhances outcomes in paroxysmal atrial fibrillation: a meta-analysis with trial sequential analysis"],"prefix":"10.1136","volume":"15","author":[{"given":"Wenchi","family":"Guan","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences Fuwai Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9353-4604","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences Fuwai Hospital, Beijing, China"},{"name":"Chinese Academy of Medical Sciences Fuwai Hospital Shenzhen Hospital, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences Fuwai Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keping","family":"Chen","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences Fuwai Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[{"name":"Arrhythmia Center, Chinese Academy of Medical Sciences Fuwai Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2025100512102202000_15.9.e095135.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809033391003"},{"key":"2025100512102202000_15.9.e095135.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.21.2619"},{"key":"2025100512102202000_15.9.e095135.3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15420\/aer.2018.50.3","article-title":"Catheter Ablation of Paroxysmal Atrial Fibrillation Originating from Non-pulmonary Vein Areas","volume":"7","author":"Higa","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2025100512102202000_15.9.e095135.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2005.00323.x"},{"key":"2025100512102202000_15.9.e095135.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.1.67"},{"key":"2025100512102202000_15.9.e095135.6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.hrthm.2015.10.023","article-title":"Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025100512102202000_15.9.e095135.7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009976","article-title":"Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH - AF Meta-Analysis Study Cohort","volume":"8","author":"Cluckey","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025100512102202000_15.9.e095135.8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1536\/ihj.16-460","article-title":"Comparison of Empiric Isolation and Conventional Isolation of Superior Vena Cava in Addition to Pulmonary Vein Isolation on the Outcome of Paroxysmal Atrial Fibrillation Ablation","volume":"58","author":"Li","year":"2017","journal-title":"Int Heart J"},{"key":"2025100512102202000_15.9.e095135.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-016-0198-2"},{"key":"2025100512102202000_15.9.e095135.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2009.01577.x"},{"key":"2025100512102202000_15.9.e095135.11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.acvd.2014.10.005","article-title":"Remote-controlled magnetic pulmonary vein isolation combined with superior vena cava isolation for paroxysmal atrial fibrillation: a prospective randomized study","volume":"108","author":"Da Costa","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"2025100512102202000_15.9.e095135.12","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euu226"},{"key":"2025100512102202000_15.9.e095135.13","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eun077"},{"key":"2025100512102202000_15.9.e095135.14","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae039","article-title":"Role of electroanatomical mapping-guided superior vena cava isolation in paroxysmal atrial fibrillation patients without provoked superior vena cava triggers: a randomized controlled study","volume":"26","author":"Dong","year":"2024","journal-title":"Europace"},{"key":"2025100512102202000_15.9.e095135.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.00953.x"},{"key":"2025100512102202000_15.9.e095135.16","doi-asserted-by":"crossref","first-page":"1028053","DOI":"10.3389\/fcvm.2022.1028053","article-title":"Single ring isolation of pulmonary veins combined with electrical isolation of the superior vena cava in patients with paroxysmal atrial fibrillation","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025100512102202000_15.9.e095135.17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10840-020-00932-6","article-title":"Comparison between superior vena cava ablation in addition to pulmonary vein isolation and standard pulmonary vein isolation in patients with paroxysmal atrial fibrillation with the cryoballoon technique","volume":"62","author":"Overeinder","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"2025100512102202000_15.9.e095135.18","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.amjcard.2020.03.030","article-title":"Effect of Combined Pulmonary Vein and Superior Vena Cava Isolation on the Outcome of Second Catheter Ablation for Paroxysmal Atrial Fibrillation","volume":"125","author":"Zhang","year":"2020","journal-title":"Am J Cardiol"},{"key":"2025100512102202000_15.9.e095135.19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013985","article-title":"Long-Term Outcome of Additional Superior Vena Cava to Septal Linear Ablation in Catheter Ablation of Atrial Fibrillation","volume":"8","author":"Jin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025100512102202000_15.9.e095135.20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10840-018-0444-x","article-title":"Persistent left superior vena cava as an arrhythmogenic source in atrial fibrillation: results from a multicenter experience","volume":"54","author":"Turagam","year":"2019","journal-title":"J Interv Card Electrophysiol"},{"key":"2025100512102202000_15.9.e095135.21","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Thomas J , Chandler J . Cochrane Handbook for Systematic Reviews of Interventions. Version 6.0.2019. Available: https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"2025100512102202000_15.9.e095135.22","unstructured":"GRADE Working Group . Grade handbook. Ontario, Canada: McMaster University and Evidence Prime, Inc, 2013. Available: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"2025100512102202000_15.9.e095135.23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1679\/aohc.58.457","article-title":"A histological study of the cardiac muscle of the human superior and inferior venae cavae","volume":"58","author":"Hashizume","year":"1995","journal-title":"Arch Histol Cytol"},{"key":"2025100512102202000_15.9.e095135.24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/157340312803760721","article-title":"Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation","volume":"8","author":"S\u00e1nchez-Quintana","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"2025100512102202000_15.9.e095135.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"key":"2025100512102202000_15.9.e095135.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"}],"updated-by":[{"DOI":"10.1136\/bmjopen-2024-095135corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000}}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:10:59Z","timestamp":1759691459000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-095135"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095135","relation":{"correction":[{"id-type":"doi","id":"10.1136\/bmjopen-2024-095135corr1","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}